IL6 and COVID-19: In this study with two well-characterized patient groups, moderate to severe COVID-19 patients (hospitalized) and mild COVID-19 patients (ambulatory), we demonstrate that D-dimer, CRP, ferritin, cardiac troponin I and IL-6 levels can facilitate the differentiation of disease severity and further support clinical decision making.